A clinical audit of Caesarean Section rates at Bangladesh Medical University according to the Robson’s Ten Group classification system


Authors

DOI:

Keywords

Bangladesh, caesarean section, clinical audit, Robson Ten Group classification

Correspondence

Farzana Islam


Email: drfarzana@bsmmu.edu.bd

Publication history

Received: 27 Feb 2026
Accepted: 4 May 2026
Published online: 10 May 2026

Responsible editor

Reviewers

C: Anonymous

Funding

None

Ethical approval

Not applicable.
This analysis is based on routine hospital data this was as a part of quality improvement process duely approved by the authority.

Trial registration number

Not applicable

Copyright

© The Author(s) 2026; all rights reserved. 
Published by Bangladesh Medical University (former Bangabandhu Sheikh Mujib Medical University).
Key messages
Among 2,405 deliveries at Bangladesh Medical University, the caesarean section rate was 69.4%. Women with a previous caesarean section (Robson Group 5) accounted for 65.6% of all caesarean deliveries, while nulliparous women undergoing induction or pre-labour caesarean (Group 2) and multiparous women without previous caesarean undergoing similar interventions (Group 4) contributed a further substantial proportion. These findings indicate that repeat caesarean sections and primary caesarean decisions are the main contributors of the high institutional caesarean rate.

Caesarean Section (CS) is one of the most frequently performed obstetric procedures worldwide, with rates increasing from approximately 7% in 1990 to over 21% in recent years [1]. The World Health Organization has suggested that population-level CS rates between 10–15% are associated with optimal maternal and neonatal outcomes [2]. However, unnecessary CS increases maternal morbidity, prolongs hospital stay, and raises the risk of complications in subsequent pregnancies.

In Bangladesh, CS rates have risen substantially over the past two decades. According to the Bangladesh Demographic and Health Survey 2022, 83% of births in private health facilities are delivered by CS compared with 36% in public facilities [3]. This trend highlights the importance of standardized audit tools such as Robson’s ten-group classification to identify key contributors and guide clinical practice[4]. Inaddition, Vaginal birth after caesarean is a safe and appropriate option for most women with a prior caesarean delivery when careful selection and adequate facilities are ensured [5]. This retrospective clinical audit was conducted at Bangladesh Medical University, Dhaka, including all deliveries from January 2023 to December 2025.

A total of 2,405 delivery records were identified. Records with missing key variables (parity, gestational age, onset of labour, fetal presentation, number of fetuses, or previous CS status) were excluded. Only 11 patient records were found to be incomplete , therefore discarded.

Data were retrospectively extracted from registers and case records using a structured form. Variables collected included maternal demographics, obstetric history, labour details, fetal presentation, delivery mode, and gestational age assessment methods were captured.

The Robson’s Ten Group Classification System, introduced by Dr. Michael S. Robson in 2001 and adopted by WHO in 2014, provides a standardized framework for auditing CS practices. It categorizes all women admitted for delivery into ten groups based on parity, gestational age, onset of labor, fetal presentation, number of fetuses, and history of caesarean section. Groups 1–4 classify term, single, cephalic pregnancies in nulliparous and multiparous women, distinguishing spontaneous labour from induction or pre-labour cesarean. Group 5 includes women with a previous caesarean at term, single, cephalic. Groups 6 and 7 cover breech presentations in nulliparous and multiparous women, respectively. Group 8 encompasses multiple pregnancies, Group 9 abnormal lies, and Group 10 preterm single cephalic pregnancies, with or without prior caesarean. This system enables consistent analysis and comparison of caesarean rates across populations.

Data were entered into Excel, checked, and descriptively analyzed. Results were reported as frequencies, percentages, proportions using Robson’s standard table. The audit findings were presented to the departmental committee, leading to recommendations for practice improvement. A re‑audit was scheduled after implementing corrective measures to complete the cycle.

Of the 2,405 deliveries, 1,671 (69.4%) were caesarean sections. As shown in Table 1, Group 5 (previous CS, singleton, cephalic, ≥37 weeks) contributed the largest proportion of caesarean sections (65.6% of all CS). Groups 2 and 4 (nulliparous and multiparous women undergoing induction or pre-labour CS) together contributed a substantial proportion of caesarean sections. Although Groups 6–10 had very high CS rates, their overall contribution was small due to fewer cases.

Table 1 Clinical audit with Robsons reporting table according to the World Health Organization Caesarean Section (CS) (n=2405)

Group

No. of CS in group

No. of women in group

Group size (%)

Group CS rate (%)

Absolute group contribution to over al CS rate (%)

Relative group contribution to over all CS rate (%)

a

b

c

d=c/N*100

e=b/c*100

f=b/N*100

g=b/M*100

Nulliparous, single cephalic, >37 weeks, spontaneous labour

5

90

3.7

5.5

0.2

0.3

Nulliparous, single cephalic, >37 weeks, induced or pre-labor CS

312

679

28.2

45.9

12.9

18.6

Multiparous (excluding previous CS), single cephalic, >37weeks, spontaneous labor.

5

123

5.1

4.0

0.2

0.3

Multiparous (excluding previous CS), single cephalic, >37weeks, induced or pre-labor CS.

140

304

12.6

46.0

5.8

8.3

Multiparous with at least one previous uterine scar, single cephalic, >37 weeks.

1097

1097

45.6

100

45.6

65.6

All nulliparous with breech presentation

13

13

0.5

100

0.5

0.7

All multiparous with breech presentation.

21

21

0.8

100

0.8

1.2

All multiple gestations.

24

24

1

100

1

1.4

All transverse or oblique malpresentations.

5

5

0.2

100

0.2

0.3

10. All single cephalic preterm gestations (<36 weeks).

49

49

2.0

100

2.0

2.9

Total

1,671 (M)

2,405 (N)

100%

69.4%

69.4%

100%

The audit demonstrates that the high institutional CS rate of 69.4% is largely attributable to repeat CS among women with a previous caesarean and primary CS among nulliparous women. This pattern underscores the critical influence of both historical obstetric decisions and current labour management practices on overall institutional CS rates.

The predominance of Group 5 (previous CS, singleton, cephalic, ≥37 weeks) highlights that vaginal birth after caesarean is not being practiced in this setting . The absence of trial of labour after caesarean suggests a reliance on elective repeat CS without standardized protocols for case selection. This raises important concerns about missed opportunities to reduce CS rates through safe vaginal birth after caesarean practices, which are supported by international guidelines when appropriate maternal and fetal conditions are met. Institutional adoption of clear vaginal birth after caesarean protocols, coupled with staff training and patient counseling, could significantly reduce the contribution of Group 5 to the overall CS burden [2, 6, 7].

The substantial contribution from Groups 2 (nulliparous, singleton, cephalic, ≥37 weeks, induced labour or CS before labour) and Group 4 (multiparous without previous CS, singleton, cephalic, ≥37 weeks, induced labour or CS before labour) emphasizes the importance of decisions surrounding primary CS. Evidence suggests that labour management practices—particularly the accurate diagnosis of labour progression, judicious use of induction, and adherence to standardized definitions of labour dystocia—play a pivotal role in determining CS rates. Overdiagnosis of “failure to progress” or inappropriate induction protocols may inflate primary CS rates, thereby putting into the cycle of repeat CS in subsequent pregnancies [1,2].

By contrast, smaller groups such as malpresentation (Group 6) and preterm births (Group 10), though associated with high CS rates, contribute minimally to the overall institutional burden. These cases are clinically expected to require surgical delivery in many instances, and their impact on the aggregate CS rate is proportionally limited [8].

Taken together, the findings suggest that institutional CS reduction strategies should prioritize two domains: firstly promoting safe vaginal birth after caesarean through standardized trial of labour after caesarean protocols to address the disproportionate contribution of Group 5 [7]. Secondly optimizing labour management and induction practices to reduce unnecessary primary CS in Groups 2 and 4.

Such targeted interventions, supported by evidence-based guidelines and robust documentation, could meaningfully lower the institutional CS rate while maintaining maternal and neonatal safety.

This audit was retrospective and relied on routinely recorded clinical data, which limited the ability to explore detailed clinical indications and decision-making processes for caesarean section. Being a single-centre study, the findings may not be generalizable to all healthcare settings in Bangladesh, particularly primary or private facilities. Additionally, as a descriptive clinical audit, causal relationships could not be established

Reducing unnecessary primary caesarean sections and promoting safe vaginal birth after caesarean are key strategies to optimize CS rates in tertiary care settings.

Variables  

Frequency (%)

Indication of colposcopy

 

Visual inspection of the cervix with acetic acid positive

200 (66.7)

Abnormal pap test

13 (4.3)

Human papilloma virus DNA positive

4 (1.3)

Suspicious looking cervix

14 (4.7)

Others (per vaginal discharge, post-coital bleeding)

69 (23.0)

Histopathological diagnosis

Cervical Intraepithelial Neoplasia 1

193 (64.3)

Cervical Intraepithelial Neoplasia 2

26 (8.7)

Cervical Intraepithelial Neoplasia 3

32 (10.7)

Invasive cervical cancer

27 (9.0)

Chronic cervicitis

17 (5.6)

Squamous metaplasia

5 (1.7)

Groups based on pre-test marks

Pretest
marks (%)

Posttest

Marks (%)

Difference in pre and post-test marks (mean improvement)

P

Didactic lecture classes

<50%

36.6 (4.8)

63.2 (9.4)

26.6

<0.001

≥50%

52.8 (4.5)

72.4 (14.9)

19.6

<0.001

Flipped classes

<50%

36.9 (4.7)

82.2 (10.8)

45.4

<0.001

≥50%

52.8 (4.6)

84.2 (10.3)

31.4

<0.001

Data presented as mean (standard deviation)

Background characteristics

Number (%)

Age at presentation (weeks)a

14.3 (9.2)

Gestational age at birth (weeks)a

37.5 (2.8)

Birth weight (grams)a

2,975.0 (825.0)

Sex

 

Male

82 (41)

Female

118 (59)

Affected side

 

Right

140 (70)

Left

54 (27)

Bilateral

6 (3)

Delivery type

 

Normal vaginal delivery

152 (76)

Instrumental delivery

40 (20)

Cesarean section

8 (4)

Place of delivery

 

Home delivery by traditional birth attendant

30 (15)

Hospital delivery by midwife

120 (60)

Hospital delivery by doctor

50 (25)

Prolonged labor

136 (68)

Presentation

 

Cephalic

144 (72)

Breech

40 (20)

Transverse

16 (8)

Shoulder dystocia

136 (68)

Maternal diabetes

40 (20)

Maternal age (years)a

27.5 (6.8)

Parity of mother

 

Primipara

156 (78)

Multipara

156 (78)

aMean (standard deviation), all others are n (%)

Background characteristics

Number (%)

Age at presentation (weeks)a

14.3 (9.2)

Gestational age at birth (weeks)a

37.5 (2.8)

Birth weight (grams)a

2,975.0 (825.0)

Sex

 

Male

82 (41)

Female

118 (59)

Affected side

 

Right

140 (70)

Left

54 (27)

Bilateral

6 (3)

Delivery type

 

Normal vaginal delivery

152 (76)

Instrumental delivery

40 (20)

Cesarean section

8 (4)

Place of delivery

 

Home delivery by traditional birth attendant

30 (15)

Hospital delivery by midwife

120 (60)

Hospital delivery by doctor

50 (25)

Prolonged labor

136 (68)

Presentation

 

Cephalic

144 (72)

Breech

40 (20)

Transverse

16 (8)

Shoulder dystocia

136 (68)

Maternal diabetes

40 (20)

Maternal age (years)a

27.5 (6.8)

Parity of mother

 

Primipara

156 (78)

Multipara

156 (78)

aMean (standard deviation), all others are n (%)

Mean escape latency of acquisition day

Groups                 

NC

SC

ColC

Pre-SwE Exp

Post-SwE Exp

Days

 

 

 

 

 

1st

26.2 (2.3)

30.6 (2.4) 

60.0 (0.0)b

43.2 (1.8)b

43.8 (1.6)b

2nd

22.6 (1.0) 

25.4 (0.6)

58.9 (0.5)b

38.6 (2.0)b

40.5 (1.2)b

3rd

14.5 (1.8) 

18.9 (0.4) 

56.5 (1.2)b

34.2 (1.9)b 

33.8 (1.0)b

4th

13.1 (1.7) 

17.5 (0.8) 

53.9 (0.7)b

35.0 (1.6)b

34.9 (1.6)b

5th

13.0 (1.2) 

15.9 (0.7) 

51.7 (2.0)b

25.9 (0.7)b 

27.7 (0.9)b

6th

12.2 (1.0) 

13.3 (0.4) 

49.5 (2.0)b

16.8 (1.1)b

16.8 (0.8)b

Average of acquisition days

5th and 6th 

12.6 (0.2)

14.6 (0.8)

50.6 (0.7)b

20.4 (2.1)a

22.4 (3.2)a

NC indicates normal control; SC, Sham control; ColC, colchicine control; SwE, swimming exercise exposure.

aP <0.05; bP <0.01.

Categories

Number (%)

Sex

 

   Male

36 (60.0)

   Female

24 (40.0)

Age in yearsa

8.8 (4.2)

Education

 

   Pre-school

20 (33.3)

   Elementary school

24 (40.0)

   Junior high school

16 (26.7)

Cancer diagnoses

 

Acute lymphoblastic leukemia

33 (55)

Retinoblastoma

5 (8.3)

Acute myeloid leukemia

4 (6.7)

Non-Hodgkins lymphoma

4 (6.7)

Osteosarcoma

3 (5)

Hepatoblastoma

2 (3.3)

Lymphoma

2 (3.3)

Neuroblastoma

2 (3.3)

Medulloblastoma

1 (1.7)

Neurofibroma

1 (1.7)

Ovarian tumour

1 (1.7)

Pancreatic cancer

1 (1.7)

Rhabdomyosarcoma

1 (1.7)

aMean (standard deviation)

Test results

Disease

Sensitivity (%)

Specificity (%)

PPV (%)

NPV (%)

Yes

No

Reid’s score ≥ 5

Positive

10

15

37.0

94.5

40.1

93.8

Negative

17

258

 

 

 

 

Swede score ≥ 5

Positive

20

150

74.1

45.0

11.8

94.6

Negative

7

123

 

 

 

 

Swede score ≥ 8

Positive

3

21

11.1

92.3

12.5

91.3

Negative

24

252

 

 

 

 

High-grade indicates a score of ≥5 in both tests; PPV indicates positive predictive value; NPV, negative predictive value

Test

Sensitivity (%)

Specificity (%)

Positive predictive value (%)

Negative predictive value (%)

Reid’s score ≥ 5

37.0

94.5

40.0

93.8

Swede score ≥ 5

74.1

45

11.8

94.6

Swede score ≥ 8

11.1

92.3

12.5

91.3

Test

Sensitivity (%)

Specificity (%)

Positive predictive value (%)

Negative predictive value (%)

Reid’s score ≥ 5

37.0

94.5

40.0

93.8

Swede score ≥ 5

74.1

45

11.8

94.6

Swede score ≥ 8

11.1

92.3

12.5

91.3

Narakas classification

Total

200 (100%)

Grade 1

72 (36%)

Grade 2

64 (32%)

Grade 3

50 (25%)

Grade 4

14 (7%)

Complete recoverya

107 (54)

60 (83)

40 (63)

7 (14)

-

Near complete functional recovery but partial deformitya

22 (11)

5 (7)

10 (16)

6 (12)

1 (7)

Partial recovery with gross functional defect    and deformity

31 (16)

7 (10)

13 (20)

10 (20)

1 (7)

No significant improvement 

40 (20)

-

1 (1.5)

27 (54)

12 (86)

aSatisfactory recovery

bGrade 1, C5, 6, 7 improvement; Grade 2, C5, 6, 7 improvement; Grade 3, panpalsy C5, 6, 7, 8, 9, Grade 4, panpalsy with Hornon’s syndrome.

Narakas classification

Total

200 (100%)

Grade-1

72 (36%)

Grade-2

64 (32%)

Grade-3

50 (25%)

Grade-4

14 (7%)

Complete recoverya

107 (54)

60 (83)

40 (63)

7 (14)

-

Near complete functional recovery but partial deformitya

22 (11)

5 (7)

10 (16)

6 (12)

1 (7)

Partial recovery with gross functional defect    and deformity

31 (16)

7 (10)

13 (20)

10 (20)

1 (7)

No significant improvement 

40 (20)

-

1 (1.5)

27 (54)

12 (86)

aSatisfactory recovery

bGrade 1, C5, 6, 7 improvement; Grade 2, C5, 6, 7 improvement; Grade 3, panpalsy C5, 6, 7,8,9, Grade 4, panpalsy with Hornon’s syndrome.

Variables in probe trial day

Groups

NC

SC

ColC

Pre-SwE Exp

Post-SwE Exp

Target crossings

8.0 (0.3)

7.3 (0.3) 

1.7 (0.2)a

6.0 (0.3)a

5.8 (0.4)a

Time spent in target

18.0 (0.4) 

16.2 (0.7) 

5.8 (0.8)a

15.3 (0.7)a

15.2 (0.9)a

NC indicates normal control; SC, Sham control; ColC, colchicine control; SwE, swimming exercise exposure.

aP <0.01.

Pain level

Number (%)

P

Pre

Post 1

Post 2

Mean (SD)a pain score

4.7 (1.9)

2.7 (1.6)

0.8 (1.1)

<0.001

Pain categories

    

   No pain (0)

-

(1.7)

31 (51.7)

<0.001

   Mild pain (1-3)

15 (25.0)

43 (70.0)

27 (45.0)

 

   Moderete pain (4-6)

37 (61.7)

15 (25.0)

2 (3.3)

 

   Severe pain (7-10)

8 (13.3)

2 (3.3)

-

 

aPain scores according to the visual analogue scale ranging from 0 to 10; SD indicates standard deviation

Surgeries

Number  

(%)

Satisfactory outcomes n (%)

Primary surgery (n=24)

 

 

Upper plexus

6 (25)

5 (83)

Pan-palsy

18 (75)

6 (33)

All

24 (100)

11 (46)

Secondary Surgery (n=26)

 

 

Shoulder deformity

15 (58)

13 (87)

Wrist and forearm deformity

11 (42)

6 (54)

All

26 (100)

19 (73)

Primary and secondary surgery

50 (100)

30 (60)

Mallet score 14 to 25 or Raimondi score 2-3 or Medical Research grading >3 to 5.

Narakas classification

Total

200 (100%)

Grade-1

72 (36%)

Grade-2

64 (32%)

Grade-3

50 (25%)

Grade-4

14 (7%)

Complete recoverya

107 (54)

60 (83)

40 (63)

7 (14)

-

Near complete functional recovery but partial deformitya

22 (11)

5 (7)

10 (16)

6 (12)

1 (7)

Partial recovery with gross functional defect    and deformity

31 (16)

7 (10)

13 (20)

10 (20)

1 (7)

No significant improvement 

40 (20)

-

1 (1.5)

27 (54)

12 (86)

aSatisfactory recovery

bGrade 1, C5, 6, 7 improvement; Grade 2, C5, 6, 7 improvement; Grade 3, panpalsy C5, 6, 7,8,9, Grade 4, panpalsy with Hornon’s syndrome.

Trials

Groups

NC

SC

ColC

Pre-SwE Exp

Post-SwE Exp

1

20.8 (0.6)

22.1 (1.8)

41.1 (1.3)b

31.9 (1.9)b

32.9 (1.8)a, b

2

10.9 (0.6)

14.9 (1.7)

37.4 (1.1)b

24.9 (2.0)b

26.8 (2.5)b

3

8.4 (0.5)

9.9 (2.0)

32.8 (1.2)b

22.0 (1.4)b

21.0 (1.4)b

4

7.8 (0.5)

10.4 (1.3)

27.6(1.1)b

12.8 (1.2)b

13.0 (1.4)b

Savings (%)c

47.7 (3.0)

33.0 (3.0)

10.0 (0.9)b

23.6 (2.7)b

18.9 (5.3)b

NC indicates normal control; SC, Sham control; ColC, colchicine control; SwE, swimming exercise exposure.

aP <0.05; bP <0.01.

cThe difference in latency scores between trials 1 and 2, expressed as the percentage of savings increased from trial 1 to trial 2

 Lesion-size

Histopathology report

Total

CIN1

CIN2

CIN3

ICC

CC

SM

0–5 mm

73

0

0

0

5

5

83

6–15 mm

119

18

1

4

0

0

142

>15 mm

1

8

31

23

12

0

75

Total

193

26

32

27

17

5

300

CIN indicates cervical intraepithelial neoplasia; ICC, invasive cervical cancer; CC, chronic cervicitis; SM, squamous metaplasia

 

Histopathology report

Total

CIN1

CIN2

CIN3

ICC

CC

SM

Lesion -Size

0-5  mm

73

0

0

0

5

5

83

6-15  mm

119

18

1

4

0

0

142

>15  mm

1

8

31

23

12

0

75

Total

193

26

32

27

17

5

300

CIN indicates Cervical intraepithelial neoplasia; ICC, Invasive cervical cancer; CC, Chronic cervicitis; SM, Squamous metaplasia

Group

Didactic posttest marks (%)

Flipped posttest marks (%)

Difference in marks (mean improvement)

P

<50%

63.2 (9.4)

82.2 (10.8)

19.0

<0.001

≥50%

72.4 (14.9)

84.2 ( 10.3)

11.8

<0.001

Data presented as mean (standard deviation)

Acknowledgements
We were grateful to the staff of the Department of Obstetrics and Gynaecology, Bangladesh Medical University, for helping us with the records.
Author contributions
Conception and design of the research: NNK, RR. Analysing the data, drafting the manuscript and revising it critically for important intellectual content: RR , FI, FN, AA. Final approval of the version to be published: FI. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved: RR.
Conflict of interest
We do not have any conflicts of interest.
Data availability statement
We confirm that the data supporting the findings of the study will be shared upon reasonable request.
AI disclosure
All scientific content, interpretations and conclusions are solely written by the authors. AI tools are used to assist in improving sentence flow and language clarity only
Supplementary file
None
    References
    1. Betran AP, Ye J, Moller AB, Souza JP, Zhang J. Trends and projections of caesarean section rates: global and regional estimates. BMJ Glob Health. 2021 Jun;6(6):e005671. doi: https://doi.org/10.1136/bmjgh-2021-005671
    2. Betran AP, Torloni MR, Zhang JJ, Gülmezoglu AM; WHO Working Group on Caesarean Section. WHO Statement on Caesarean Section Rates. BJOG. 2016 Apr;123(5):667-670. doi: https://doi.org/10.1111/1471-0528.13526
    3. National Institute of Population Research and Training (NIPORT), ICF. Bangladesh Demographic and Health Survey 2022. Available at: https://www.dhsprogram.com/pubs/pdf/FR386/FR386.pdf [Accessed on 6 May 2026].
    4. Robson MS. Classification of caesarean sections. Fetal Maternal Med Rev. 2001;12:23–39. Robson M. Classification of caesarean sections. Fetal and Maternal Medicine Review. 2001;12(1):23-39. doi: https://doi.org/10.1017/S0965539501000122
    5. American College of Obstetricians and Gynecologists. Vaginal Birth After Cesarean Delivery. Practice Bulletin No. 205. 2019. Vaginal Birth After Cesarean Delivery. Obstet Gynecol. 2019 Feb;133(2):e110-e127. doi: https://doi.org/10.1097
    6. Tanaka K, Mahomed K. The Ten-Group Robson Classification: A Single Centre Approach Identifying Strategies to Optimise Caesarean Section Rates. Obstet Gynecol Int. 2017;2017:5648938. doi: https://doi.org/10.1155/2017/5648938
    7. Rahman R, Nasrin B, Laila TR, Aktar F, Khanam NN. Outcome of trial of labour for vaginal birth after one caesarean section. Bangabandhu Sheikh Mujib Medical University Journal. 2026;19(1): e82199. doi: https://doi.org/10.3329/bsmmuj.v19i1.82199
    8. Nigam M, Gusain N, Upadhyay R. Patterns and indications of caesarean sections in a tertiary care hospital: a Robson Ten-Group Classification analysis. Eur J Med Res. 2025 Dec 26;31(1):158. https://doi.org/10.1186/s40001-025-03636-7